These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16227158)

  • 1. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
    Kjellström J; Kjellén E; Johnsson A
    Acta Oncol; 2005; 44(7):687-93. PubMed ID: 16227158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.
    Hector S; Tummala R; Kisiel ND; Diegelman P; Vujcic S; Clark K; Fakih M; Kramer DL; Porter CW; Pendyala L
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):517-27. PubMed ID: 17987291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
    Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
    Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin activity in head and neck cancer cell lines.
    Espinosa M; Martinez M; Aguilar JL; Mota A; De la Garza JG; Maldonado V; Meléndez-Zajgla J
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):301-5. PubMed ID: 15619139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
    van der Wilt CL; Kuiper CM; Peters GJ
    Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining radiation with oxaliplatin: a review of experimental results.
    Hermann RM; Rave-Fränk M; Pradier O
    Cancer Radiother; 2008 Jan; 12(1):61-7. PubMed ID: 18243751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.
    François E; Ychou M; Ducreux M; Bertheault-Cvitkovic F; Giovannini M; Conroy T; Lemanski C; Thomas O; Magnin V;
    Eur J Cancer; 2005 Dec; 41(18):2861-7. PubMed ID: 16297614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of oxaliplatin against human tumor colony-forming units.
    Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
    Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure-response relationships for oxaliplatin-treated colon cancer cells.
    Kirstein MN; Root SA; Moore MM; Wieman KM; Williams BW; Jacobson PA; Marker PH; Tuttle TM
    Anticancer Drugs; 2008 Jan; 19(1):37-44. PubMed ID: 18043128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation induction of drug resistance in RIF-1 tumors and tumor cells.
    Hopwood LE; Moulder JE
    Radiat Res; 1989 Nov; 120(2):251-66. PubMed ID: 2616741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin as a radiosensitizing agent in rectal cancer.
    Huerta S; Hrom J
    Anticancer Drugs; 2011 Apr; 22(4):317-23. PubMed ID: 21285866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous radiosensitizing chemotherapy].
    Hennequin C; Maylin C
    Pathol Biol (Paris); 1999 Mar; 47(3):279-81. PubMed ID: 10214623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of uterine cancer cell lines by cytotoxic agents.
    Nguyen HN; Sevin BU; Averette HE; Gottlieb C; Perras J; Donato D; Penalver M
    Gynecol Oncol; 1993 Jan; 48(1):16-22. PubMed ID: 8423017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells.
    Rave-Fränk M; Schmidberger H; Christiansen H; Boll C; Lehmann J; Weiss E
    Int J Radiat Biol; 2007 Jan; 83(1):41-7. PubMed ID: 17357438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
    Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
    Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.
    Dolinsky CM; Mahmoud NN; Mick R; Sun W; Whittington RW; Solin LJ; Haller DG; Giantonio BJ; O'Dwyer PJ; Rosato EF; Fry RD; Metz JM
    J Surg Oncol; 2007 Sep; 96(3):207-12. PubMed ID: 17443718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
    Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
    J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.